{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Baroness+Bennett+of+Manor+Castle&min-answer.questionFirstAnswered.=2018-11-20T16%3A18%3A11.853Z&ddpCreated=2023-07-10T21%3A11%3A09.223Z", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberPrinted.=Baroness+Bennett+of+Manor+Castle&min-answer.questionFirstAnswered.=2018-11-20T16%3A18%3A11.853Z&ddpCreated=2023-07-10T21%3A11%3A09.223Z", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Baroness+Bennett+of+Manor+Castle&min-answer.questionFirstAnswered.=2018-11-20T16%3A18%3A11.853Z&_metadata=all&ddpCreated=2023-07-10T21%3A11%3A09.223Z", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Baroness+Bennett+of+Manor+Castle&_page=0&min-answer.questionFirstAnswered.=2018-11-20T16%3A18%3A11.853Z&ddpCreated=2023-07-10T21%3A11%3A09.223Z", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Baroness+Bennett+of+Manor+Castle&min-answer.questionFirstAnswered.=2018-11-20T16%3A18%3A11.853Z&ddpCreated=2023-07-10T21%3A11%3A09.223Z", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Baroness+Bennett+of+Manor+Castle&min-answer.questionFirstAnswered.=2018-11-20T16%3A18%3A11.853Z&ddpCreated=2023-07-10T21%3A11%3A09.223Z", "items" : [{"_about" : "http://data.parliament.uk/resources/1651487", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1651487/answer", "answerText" : {"_value" : "<p><del class=\"ministerial\">The early access to medicines scheme (EAMS) aims to give patients with life threatening or seriously debilitating conditions access to medicines that do not yet have a marketing authorisation when there is a clear unmet medical need.<\/del><\/p><p><del class=\"ministerial\">Under the scheme, the Medicines and Healthcare products Regulatory Agency (MHRA) will give a scientific opinion on the benefit/risk balance of the medicine, based on the data available when the EAMS submission was made and the EAMS criteria. The MHRA will make an evaluation of products, including drugs such as for brain tumour treatments, once an application is received.<\/del><\/p><p><del class=\"ministerial\">If we do receive an application, it is only made public where an EAMS Scientific Opinion (SO) is awarded. All EAMS SOs are published on the EAMS webpage. All drugs that have previously held an EAMS SO are also published on the EAMS webpage.<\/del><\/p><p><ins class=\"ministerial\">The Pharmacy Access Scheme provides additional funding to pharmacies where the next nearest pharmacy is more than a 20-minute walk away. This is calculated as a 0.8-mile walking distance in areas of high deprivation and 1 mile in other areas. In 2021, we agreed updated eligibility criteria and an updated payment model with Community Pharmacy England. To be eligible for the payment, pharmacies must deliver the Community Pharmacist Consultation Service. Quality and opening hours are not included in the eligibility criteria.<\/ins><\/p><p> <\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Markham"}
        , "dateOfAnswer" : {"_value" : "2023-07-19", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1651487/answer/previousversion/88780", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"}
          }
          , "answeringMemberPrinted" : {"_value" : "Lord Markham"}
        }
        , "questionFirstAnswered" : [{"_value" : "2023-07-19T15:05:50.113Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2023-07-20T15:18:01.373Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2023-07-10", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Pharmacy: Standards"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask His Majesty's Government what assessment they have made of the level of support available under the Pharmacy Access Scheme; and whether the criteria includes the (1) quality, (2) opening hours, and (3) range of provision, of existing pharmacies.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
      ], "uin" : "HL9200"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}